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The use of alternative solvents in the iridium-catalysed hydrogen isotope exchange reaction with 
developing phosphine/NHC Ir(I) complexes has identified reaction media which are more widely 
applicable and industrially acceptable than the commonly employed chlorinated solvent, dichloromethane. 
Deuterium incorporation into a variety of substrates has proceeded to deliver high levels of labelling (and  
regioselectivity) in the presence of low catalyst loadings and over short reaction times. The preparative 
outputs have been complemented by DFT studies to explore ligand orientation, as well as solvent and 
substrate binding energies within the catalyst system. 
Introduction 
With attrition rates in the drug development process at such an 
elevated level,1 identification of any failing attributes of 
potential drug candidates at an early stage constitutes a strategy 
of appreciable focus within the pharmaceutical industry. 
Associated with this, the isotopic labelling of such molecules 
provides a fast and efficient method of incorporating a tracer 
into compounds of interest, enabling various metabolic, 
stability, and toxicity studies to be performed.2 In this regard, 
hydrogen isotope exchange (HIE) potentially provides the most 
direct method of achieving such a labelling procedure in one 
preparative step. Accordingly, the development of methods and 
catalyst species which mediate hydrogen isotope exchange 
processes continues to be the subject of appreciable research 
focus, with these techniques, as well as alternative labelling 
strategies, being the subject of recent special issues and review 
articles.3 
 
Although a number of transition metal species have been shown 
to catalyse H-D exchange,3-7 &UDEWUHH¶V FDWDO\VW
[Ir(COD)(PCy3)(py)]PF6
8a,b has been regarded as the optimal 
complex to facilitate this transformation. Having stated this, it 
is often found that high levels of incorporation can only be 
achieved in the presence of (super-)stoichiometric quantities of 
this Ir complex and after extended periods of time.8b-g Research 
within our own laboratory has focused on the synthesis and use 
of highly active complexes of the type 
[Ir(COD)(PR3)(IMes)]PF6 2, which display high activity in the 
isotopic labelling of a number of substrates classes.9 
Furthermore, such complexes are readily handled and deliver  
 
 
Scheme 1 Isotopic labelling with Ir(I) complexes 2. 
excellent levels of incorporation at low catalyst loadings and 
over short reaction times (Scheme 1). Despite the efficiency 
that has been evidenced to date with catalysts 2, a drawback of 
the developed system relates to the use of dichloromethane 
(DCM) as the reaction medium. From an industrial perspective, 
the employment of this chlorinated solvent is deemed 
unfavourable due to its associated hazards, including suspected 
carcinogenicity and high vaporisability. Indeed, pharmaceutical 
companies are now driving specifically towards the 
replacement of DCM with solvents that are believed to be more 
industrially acceptable.10 Furthermore, the identification of 
suitable alternatives to DCM would have further and not 
inconsiderable benefits within medicinal chemistry research 
endeavours due to the low solubility of numerous potential drug 
candidates in this reaction medium. To date, various research 
groups have examined the application of solvents other than 
DCM in the field of hydrogen isotope exchange, however, with 
varying success.6q,8c-e,11 In view of these considerations, the 
study presented herein describes our most recent endeavours to 
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further develop the efficiency and applicability of our emerging 
catalysts 2 within HIE reactions, whilst striving to enhance the 
wider practical utility of these methods. 
Results and Discussion 
Our initial investigations involved the screening of a number of 
solvents using the otherwise standard conditions developed 
within our laboratory. As illustrated by the results displayed in 
Table 1, the isotopic labelling of the simple substrate 
acetophenone 1, using 5 mol% of complex 2a (R = Ph) over a 
16 h reaction time, proceeded to varying degrees of deuteration 
in the selected reaction media. The first attempt to mediate HIE 
in an alternative solvent, Et2O, delivered the isotopically-
enriched product 3 in a level of deuterium incorporation 
comparable to that obtained previously in DCM (cf. Scheme 
1)9a Such a high degree of isotope exchange was maintained 
upon moving to the more sterically hindered and less volatile t-
BuOMe. Unfortunately, but perhaps somewhat expectantly, the 
reaction performed in acetone produced only a moderate 
deuterium loading of 43%. Finally, the use of 2-MeTHF as an 
alternative reaction medium for HIE reactions was examined. 
The use of this solvent has increased greatly within the 
pharmaceutical industry over recent years and following its 
identification as a potential replacement for DCM in other areas 
of preparative chemistry, due to its high polarity but low 
miscibility with water.12 Pleasingly, the use of this solvent in H-
D exchange reactions proceeded without incident, furnishing 
the desired product with an excellent 95% level of deuteration. 
 
Table 1 Solvent Screening 
 
Entry Solvent % D a) 
1 Et2O 94 
2 t-BuOMe 91 
3 acetone 43 
4 2-MeTHF 95 
a) Average incorporation into the positions shown over two separate reaction 
runs; the percentage given refers to the level of D incorporation over the total 
number of positions possible, e.g. 94% for the two possible positions in 3 
indicates 1.88D incorporation. 
In view of these findings, Et2O, t-BuOMe, and 2-MeTHF were 
selected for further investigation. As mentioned, our Ir(I) 
complexes display excellent levels of activity in HIE reactions 
performed in DCM (Scheme 1).9a It was therefore of interest to 
determine if such an efficient catalytic procedure would be 
retained in systems utilising the described alternative solvents. 
Following a short series of optimisation studies, the most 
effective conditions for the isotopic labelling of acetophenone 1 
were identified for complexes 2a and 2b (Table 2), with 
excellent levels of deuterium incorporation being observed over 
relatively short reaction times. 
Table 2 Optimised conditions for HIE in alternative solvents 
 
Entry Solvent Complex 
(PR3) 
Mol% Time 
(h) 
% D 
1 Et2O 2a (PPh3) 3 2 92 
2 Et2O 2b (PBn3) 3 1 97 
3 t-BuOMe 2a (PPh3) 5 2 91 
4 t-BuOMe 2b (PBn3) 5 2 94 
5 2-MeTHF 2a (PPh3) 3 2 95 
6 2-MeTHF 2b (PBn3) 3 1 96 
 
At this stage and, importantly, to gain further insight into our 
observations regarding the performance of complexes of class 2 
in HIE reactions, both in a general sense and as conducted in 
the alternative solvents, a series of theoretical studies were 
undertaken.13 In accordance with the proposed mechanism by 
which isotope exchange occurs, as reported by Heys,14 it was 
assumed that following activation of our Ir(I) complexes 
through loss of d4-cyclooctane, the resulting coordinatively 
unsaturated Ir species may be stabilised by the coordination of 
two solvent (S) molecules (5, Scheme 2). 
 
 
 
Scheme 2 Complex activation and solvent coordination. 
 
Fig. 1 Optimised structure of the Ir species with two solvent molecules (2-
MeTHF) coordinated (distances are in Å and angles in degrees). 
In line with the pathway proposed, we have located stable bi-
solvent complexes for the five different solvents investigated 
(the optimised structure of 2-MeTHF coordinated to the iridium 
complex is shown in Figure 1; coordinates of all optimised 
structures are provided in the Electronic Supplementary 
Information). In all cases, the optimised structures illustrated 
that the phosphine and NHC ligands align in a trans-
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configuration around the metal centre within the activated 
species. Further and in order for the reaction to progress, the 
dissociation of the solvent molecules from the metal centre 
must constitute a favourable process to enable subsequent 
coordination of the incoming substrate molecule (Scheme 2, 
5ĺ7). We therefore examined the explicit binding enthalpies of 
WKHVROYHQWPROHFXOHVǻ+sol), as illustrated in Scheme 3.15 
 
 
Scheme 3 ĂůĐƵůĂƚŝŽŶŽĨƐŽůǀĞŶƚďŝŶĚŝŶŐĞŶƚŚĂůƉǇ ?ѐ,sol).    
For each solvent LQYHVWLJDWHG WKH ELQGLQJ HQWKDOSLHV ǻ+sol) 
were found to be exothermic (Table 3). The variation in the 
degree of deuteration between different solvents can be affected 
by the strength of the interaction between the solvent molecule 
and the iridium centre, with a larger binding enthalpy 
potentially having an undesirable effect on % D. Of the 
solvents investigated, DCM was found to have the lowest 
binding enthalpy. The most weakly coordinating of the ethereal 
reaction media was found to be t-BuOMe, followed by Et2O, 
and then 2-MeTHF, with acetone displaying the highest binding 
enthalpy. Accordingly, it is proposed that the binding enthalpy 
calculated for the more strongly coordinating acetone lies 
beyond the acceptable values required to favour dissociation of 
the solvent and, in turn, effective catalysis. 
 
Table 3 &DOFXODWHGVROYHQWELQGLQJHQWKDOSLHV¨+sol, kcal/mol) for five 
different solvents. 
Entry Species ¨+sol 
1 Ir(D)2(PMe3)(IMes)(DCM)2 -13.1 
2 Ir(D)2(PMe3)(IMes)(t-BuOMe)2 -17.5 
3 Ir(D)2(PMe3)(IMes)(Et2O)2 -26.8 
4 Ir(D)2(PMe3)(IMes)(2-MeTHF)2 -33.0 
5 Ir(D)2(PMe3)(IMes)(acetone)2 -38.6 
 
As presented in Scheme 2, the second step of the reaction 
mechanism is the exchange of one solvent molecule with a 
substrate unit at the metal centre. We were therefore interested 
in determining the corresponding binding enWKDOSLHV ¨+exc) 
associated with such a substitution (Scheme 4). As anticipated, 
the substrate binding enthalpies follow the reverse order to that 
observed previously for the solvent binding (Table 4). 
 
 
Scheme 4 ĂůĐƵůĂƚŝŽŶŽĨƐƵďƐƚƌĂƚĞďŝŶĚŝŶŐĞŶƚŚĂůƉǇ ?ѐ,exc). 
Table 4 Calculated binding enWKDOSLHV¨+exc, kcal/mol) associated with 
the exchange of one solvent molecule with acetophenone. 
Entry Species ¨+exc 
1 Ir(D)2(PMe3)(IMes)(PhCOMe)(DCM) -13.3 
2 Ir(D)2(PMe3)(IMes)(PhCOMe) 
(t-BuOMe) 
-12.8 
3 Ir(D)2(PMe3)(IMes)(PhCOMe)(Et2O) -7.3 
4 Ir(D)2(PMe3)(IMes)(PhCOMe) 
(2-MeTHF) 
-3.7 
5 Ir(D)2(PMe3)(IMes)(PhCOMe)(acetone) 0.3 
 
More specifically, systems in which solvent molecules bind 
least strongly to the Ir centre are, consequently, stabilised to the 
highest degree by the exchange of the solvent molecule with the 
substrate, and vice versa ,PSRUWDQWO\ WKHFDOFXODWLRQRI¨+exc 
provides a much clearer indication of the solvents that will 
support deuteration of the substrate. The substitution of DCM 
or ethereal solvent molecules by acetophenone occurs in an 
exothermic reaction (i.e. the equilibrium is shifted towards the 
substrate coordinated complex, which is then able to undergo 
deuteration). Conversely, the exchange of acetone with a 
substrate molecule occurs in a thermo-neutral (slightly 
endothermic) reaction. As such, the substrate bound complex 
will be present in appreciably lowered proportions, resulting in 
decreased deuterium incorporation. The difference in the 
direction of the equilibrium, as shown by the calculated ¨Hexc, 
in the presence of acetone in contrast with the other four 
solvents aligns with the difference between the levels of H-D 
exchange observed in the reactions. This delicate balance 
between solvent and substrate binding enthalpies is clearly 
important in determining the ability of the reaction to occur. 
However, once bound, the solvent may also affect the activity 
of the catalyst through polarising the medium in which the 
reaction occurs. These more subtle effects of the solvent on the 
reaction mechanism may further account for the differences in 
deuteration levels observed between DCM and the ethereal 
solvents investigated within this study. 
 
Having established the optimum conditions for H-D exchange 
reactions performed in alternative reaction media, their 
application in the isotopic labelling of a range of substrates was 
explored with complex 2b (Figure 2). In a number of instances, 
such as the labelling of heterocyclic compounds 11 and 12, and 
methyl-substituted amides 14 and 15, the use of lower catalyst 
loadings and shorter reaction times in the three solvents under 
investigation delivered high levels of isotope incorporation, as 
compared to those obtained previously in DCM.9a With regards 
to substrates 13, 16, and 17, marginally more elevated 
conditions catalyst loadings (5 mol%) and longer reaction times 
(16 h), were required to furnish increased levels of deuterium 
exchange. Of particular interest was the isotopic labelling of 
notoriously more demanding substrates, benzamide 13 and 
acetanilide 17. While reactions run in Et2O and t-BuOMe failed 
to reach deuterium incorporations which were comparable to 
those attained in DCM,9a the use of 2-MeTHF with these 
systems greatly improved the degree of deuteration achieved; 
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with regards to benzamide 13 an excellent 89% was recorded, 
the highest D loading obtained so far for this substrate using 
complexes of this type. 
 
 
 
a3 mol%, 1 h; b5 mol%, 2 h; c3 mol%, 1 h; d5 mol%, 16 h. 
Fig. 2 Widening substrate scope with complex 2b. 
In further extending the substrates investigated, application of 
benzanilide 18 allows the selectivity scope of the labelling 
processes in an ethereal solvent medium to be probed.9a As 
shown in Scheme 5, following only 1 h reaction in 2-MeTHF 
with complex 2b (3 mol%), an appreciable degree of preference 
was shown for H-D exchange via a five-membered 
metallocyclic intermediate (5-mmi, site a) over a six-membered 
metallocyclic intermediate (6-mmi, site b). Such levels of 
regioselective isotope incorporation could provide significant 
value in the directed labelling of more complex drug-like 
molecules under the mild and more practically acceptable 
conditions developed here.  
 
 
Scheme 5 Selective deuteration of benzanilide. 
Additional success was revealed in the isotopic labelling of 
3IL]HU¶VDQWKHOPLQWLF1iclosamide 20. As illustrated in Table 5, 
reactions employing 2b with DCM as the solvent gave rise to 
only moderate levels of labelling in each of the four positions at 
which exchange is possible, with no significant site selectivity 
between being observed. A low preference for the position of 
exchange was also apparent in HIE reactions conducted in 
Et2O; however, in this instance, the extent of isotope 
incorporation was somewhat higher than with DCM as the 
reaction medium. The deuteration of 20 in the presence of t-
BuOMe and 2-MeTHF delivered significantly improved overall 
levels of labelling and up to 97% D loading. In addition, results 
from the latter reactions indicated a clear preference for H-D 
exchange which occurs through the more favourable 5-mmi 
(site d) versus a 6-mmi (site c), implying that a high degree of 
selectivity could be attained in the labelling of alternative 
compounds that possess such competing possible sites. Further, 
in this specific example, the elevated levels of isotope 
incorporation observed in the alternative solvents is proposed to 
be due to the higher solubility of 20 in the more polar reaction 
media. Such results therefore reinforce the importance of the 
ability to perform HIE reactions in media other than DCM, and, 
in particular, those solvents which are capable of solubilising 
more polar drug molecules. 
 
Table 5 Isotopic labelling of Niclosamide 
 
Entry Solvent Mol% Time % D 
 a b c d 
1 DCM 5 1 55 44 40 58 
2 Et2O
 3 1 75 70 63 76 
3 t-BuOMe 5 2 83 48 37 87 
4 2-MeTHF 3 1 89 55 28 97 
 
Conclusions 
Overall, we have illustrated that exceptional levels of 
deuteration can be maintained when employing the recently 
developed complexes 2 in more widely acceptable ethereal 
solvents. Furthermore, only low levels of catalyst loading are 
required with the desired labelled products being delivered over 
short reaction times to provide more generally convenient and 
applicable preparative protocols. In addition to this, 
investigation of the binding enthalpies associated with both the 
mono- and di-solvent complexes for five different reaction 
media has provided emerging insight into the reactivity of the 
Ir(I) catalyst in the various solvents aligned with the level of 
isotopic labelling observed. 
Experimental Section 
General 
All solvents were purified prior to their use. Dichloromethane 
and 2-methyltetrahydrofuran were dried by heating to reflux 
over calcium hydride, and then distilled under nitrogen. Diethyl 
ether was dried by heating to reflux over sodium wire, and then 
distilled under nitrogen. Acetone and tert-butylmethyl ether 
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were dried by heating to reflux over calcium sulfate, and then 
distilled under nitrogen. Acetanilide, benzamide, and 
benzanilide were purified by recrystallisation from ethanol. 
Standard Procedure for Hydrogen Isotope Exchange 
To a flame-dried, 100 mL, three necked round bottomed flask, 
fitted with two stopcock valves and a suba seal, was added the 
iridium(I) complex, substrate, and dry solvent. The suba seal 
was replaced with a glass stopper, fitted with a Teflon sleeve, 
and the solution was placed in a dry ice/acetone slurry bath and 
cooled to -78 °C. The flask was evacuated three times, filled 
with nitrogen in the first two instances, and with deuterium in 
the third. The flask was then removed from the slurry bath and 
placed in a water bath set at 25°C. (NOTE: the glass stopper 
must be physically restrained as the reaction mixture warms to 
room temperature). The solution was then stirred vigorously for 
the allotted reaction time. The flask was evacuated to remove 
excess deuterium from the system. The contents of the flask 
and washings were then transferred to a single necked flask, 
and concentrated in vacuo. The catalyst was precipitated from 
the residue by addition of diethyl ether (~10 mL) and the 
solution filtered through a short plug of silica. The solvent was 
then removed under reduced pressure. The level of isotope 
incorporation achieved was determined by 1H NMR analysis of 
the reaction products. As such, the relevant integral for the 
residue proton signal from the site of incorporation was 
compared against that of a site where exchange would not be 
expected to occur.  
Theoretical Methods13,15 
All structures have been optimised at the M06/[6-31G(d,p) for 
H, C, O, N, P, Cl + Stuttgart RECP and associated basis set for 
Ir level of theory in Gaussian 09. Frequency calculations were 
also performed at this level of theory to fully characterise the 
stationary states as minima and to determine the 
thermodynamic parameters. 
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